Minnesota Cannabis Law Changes August 1, 2026: Your Complete Guide to the Omnibus Bill
On May 26, 2026, Governor Tim Walz signed the 2026 Omnibus Cannabis Bill into law, setting in motion the most sweeping overhaul of Minnesota's cannabis regulations since adult-use sales launched in 2025. Sponsored by Representative Jessica Hanson (DFL-Burnsville) and described by Hanson as a "collaborative effort" involving more than 80 stakeholders, the law touches nearly every corner of the industry, from supply chain logistics and medical patient access to hemp industry lifelines and a brand-new license tier.
Most provisions take effect August 1, 2026, now just one month away. A smaller set of changes, chiefly the new macrobusiness license framework, become effective January 1, 2027. Here is what you need to know, broken down by who it affects.
What Changes on August 1, 2026
1. One Supply Chain for Medical and Adult-Use Businesses
The most operationally significant change in the law is the merger of Minnesota's bifurcated medical and adult-use supply chains. Under the old framework, businesses holding a medical cannabis endorsement had to maintain entirely separate cultivation operations, manufacturing lines, and inventory tracking systems, including separate instances within the state's Metrc seed-to-sale platform.
Starting August 1, that requirement goes away. Businesses with a medical endorsement may now run a single, unified operation covering cultivation, manufacturing, and inventory, all tracked through one Metrc instance.
"Every state that has rolled out an adult-use program following a medical marijuana program has merged supply chains to some extent. Here, Minnesota follows suit." -- Canna Law Blog, Harris Sliwoski LLP
The practical result: lower overhead for multi-endorsement operators and less duplication across compliance systems. Dispensaries serving both populations will no longer need to segregate product flows from the point of cultivation all the way to the shelf. Find licensed dispensaries near you to see which operators hold medical endorsements in your area.
2. Stronger Medical Patient Protections
The supply chain merger comes with a carefully constructed set of patient safeguards designed to ensure the medical market does not get absorbed into the adult-use flow without patient interests protected.
Businesses holding a medical retail endorsement must now:
- Employ a licensed pharmacist or medical cannabis consultant to provide patient consultations on site or by telephone.
- Establish priority service protocols for registered patients, such as dedicated check-in lines, curbside pickup, and advance ordering systems.
- Carry all products identified by OCM as having high medical need, including formulations for rare and childhood diseases.
- Fulfill medical patient product requests within 24 hours.
Certain medical cannabis products are also exempt from the adult-use potency limits that apply to recreational products. Hemp-derived cannabinoids are now permitted in medical formulations, opening additional options for patients whose conditions require specific cannabinoid profiles.
Representative Hanson highlighted the urgency of these protections during House debate, noting that patients, including children with epilepsy and debilitating autoimmune diseases, had faced limited product access under the previous framework.
3. Dual Licensure: Hemp Operators Can Enter the Cannabis Market
One of the most significant lifelines in the bill is directed at Minnesota's hemp industry. The law authorizes dual licensure, allowing the same ownership group to hold both hemp and cannabis (marijuana) licenses simultaneously. Previously, those markets were walled off from each other at the ownership level.
This matters enormously in light of the federal regulatory calendar. A federal re-definition of "hemp" is set to take effect November 12, 2026, which will significantly narrow what can legally be sold under federal hemp rules. The Minnesota legislation gives hemp operators a runway to transition into the regulated cannabis market before that federal shift squeezes their product options.
The law also creates a new product category: ratio hemp-infused cannabis products. These must stay within the following limits:
- No more than 100 milligrams of CBD, CBG, CBN, or CBC per serving.
- No more than 10 milligrams of THC per serving.
- No more than 200 milligrams of THC per package for edibles, or two servings per container for beverages.
Explore Minnesota's current cannabis product landscape and strain options to understand where these new formulations fit within the broader market.
4. OCM Gets Broader Enforcement Authority
The Office of Cannabis Management gains expanded powers under the new law. Starting August 1:
- OCM may deny or revoke licenses on broader grounds, with clearer authority to act on compliance failures.
- Preliminary license approvals must include mandatory extension rights, giving applicants more protection during the approval pipeline.
- OCM transitions to a streamlined reporting structure: one annual market analysis and one consolidated legislative report due by January 15 each year. The previous reporting framework had become unwieldy, and the new bifurcated structure is intended to prioritize useful public health, safety, and market data.
5. Local Government Licensing Rules Get Standardized
The law requires local governments to adopt reasonable cannabis regulations and to apply population-based licensing thresholds using upward rounding. This provision addresses patchwork local rules that had created inconsistency across municipalities in how many dispensaries could operate per capita.
6. Social Equity Applicants Can Hold More Licenses
Social equity license applicants may now hold up to four licenses with capped ownership stakes. Previously, license caps were more restrictive for social equity operators, limiting the scale of businesses that could be built by qualifying individuals. This change is intended to support wealth-building opportunities for communities disproportionately affected by cannabis prohibition.
7. Cannabis and Hemp Activities Expressly Protected Under State Law
The new law codifies explicit protections for compliant cannabis and hemp business activities under Minnesota state law. This is a legal housekeeping provision, but an important one: it creates clearer ground for businesses to operate without civil liability risk from state-level interference, even as federal status remains complicated.
What Changes on January 1, 2027
The New Macrobusiness License
The existing medical cannabis combination business license will sunset on January 1, 2027. In its place, the law creates the macrobusiness license, a new top-tier category in Minnesota's size-tiered licensing structure.
Key parameters of the macrobusiness license:
- Up to 38,000 square feet of indoor plant canopy. This is a significant reduction from the current 90,000 square feet allowed for medical cannabis combination businesses.
- Up to eight retail locations. If a macrobusiness operates more than five retail locations, at least three must be located in areas OCM designates as high medical need.
- A statewide cap of eight macrobusiness licenses until January 1, 2030.
- Macrobusinesses are the only license type required to serve the medical market, and they must hold at least two medical endorsements.
For operators concerned about the canopy reduction, the law does include a gradual restoration path: macrobusinesses in good standing can earn back canopy through license renewals, gaining an additional 2,000 square feet after their first renewal, another 2,000 after the second, and an additional 3,000 after the third.
All existing medical cannabis combination business licenses must be converted to macrobusiness licenses or applications by January 1, 2027. OCM is responsible for managing that conversion process.
Representative Nolan West (R-Blaine) called the canopy reduction "the worst part of the bill," warning it could invite litigation from current operators who built their businesses around larger canopy allowances. That tension is worth watching as implementation proceeds.
The law also introduces a petition process for microbusinesses and mezzobusinesses that want to move into a higher license tier, with priority given to businesses holding medical endorsements and equal allocation between social equity and non-social equity applicants.
Incentives for Medical Endorsement Holders
Across all license types, the law creates meaningful incentives for businesses that voluntarily obtain a medical cannabis endorsement. Cultivators, mezzobusinesses, and microbusinesses with medical endorsements receive:
- Expanded cultivation limits above what non-endorsed businesses may grow.
- Rights to operate additional retail locations in designated high medical need areas.
- Authority to deliver directly to patients and caregivers, a new avenue for patient access.
- Expanded transport rights that allow endorsed businesses to move product more efficiently across the supply chain.
In exchange, a portion of any increased production capacity must be supplied to other medical-endorsed businesses. The law frames this as a reciprocal obligation designed to keep the medical supply chain stocked even as the adult-use market continues to grow.
What This Means for Consumers
If you are a Minnesota cannabis consumer or patient, here is the practical takeaway:
Medical patients will see improved access. More businesses will have an incentive to hold medical endorsements, product availability should improve, and the 24-hour fulfillment requirement gives you a new baseline expectation when requesting specific medical products.
Adult-use consumers will notice fewer differences in the short term. The supply chain merger primarily affects back-end operations; dispensary shelves and the retail experience should remain largely consistent. Over time, the macrobusiness framework and expanded cultivation rights may shift which operators dominate the market.
Hemp consumers should pay attention to the new ratio hemp-infused cannabis products when they begin appearing in licensed dispensaries. These products are formulated within defined cannabinoid limits and will be sold through the regulated cannabis supply chain, meaning they come with the same testing and labeling standards as other cannabis products. Check out the legal overview for Minnesota cannabis to understand how the regulatory environment is evolving.
What This Means for Dispensaries and Businesses
If you operate or plan to open a Minnesota dispensary, here is what to prioritize before August 1:
- Evaluate your Metrc configuration. If you currently hold a medical endorsement and maintain separate tracking instances, work with your compliance team now to plan a unified tracking setup.
- Review your staffing. The pharmacist or medical cannabis consultant requirement is mandatory for retail medical endorsement holders. Begin hiring or contracting if you do not have this role filled.
- Audit your patient service protocols. Priority service infrastructure, curbside pickup, advance ordering, and 24-hour fulfillment obligations need to be in place by August 1 if you hold a medical endorsement.
- If you operate a hemp business, consult legal counsel about dual licensure and the federal November 2026 deadline. The window to plan a transition into the cannabis market is open now; waiting until fall may be too late.
- Watch OCM guidance on macrobusiness conversion. If you are a current medical cannabis combination business, the January 1, 2027 deadline is coming faster than it looks. OCM will issue conversion procedures; stay close to those communications.
Frequently Asked Questions
When does the 2026 Omnibus Cannabis Bill take effect?
Most provisions take effect August 1, 2026. The macrobusiness license framework, including conversion of existing medical cannabis combination business licenses, takes effect January 1, 2027.
What is the new macrobusiness license in Minnesota?
The macrobusiness license is a new top-tier cannabis license that replaces the existing medical cannabis combination business license. It allows up to 38,000 square feet of indoor canopy and up to eight retail locations. It is the only license type required to serve the medical market. The macrobusiness license becomes available January 1, 2027, with a statewide cap of eight licenses until 2030.
Can hemp and cannabis businesses be owned by the same person under Minnesota's new law?
Yes. Starting August 1, 2026, the law allows dual licensure, meaning the same owner can hold both hemp and cannabis licenses. This was not permitted under the previous framework.
What are the rules for the new ratio hemp-infused cannabis products?
Ratio hemp-infused cannabis products must contain no more than 100 milligrams of CBD, CBG, CBN, or CBC per serving, no more than 10 milligrams of THC per serving, and no more than 200 milligrams of THC per package for edibles (or two servings per container for beverages). They will be sold through the licensed cannabis supply chain.
Do medical patients get better protections under the new law?
Yes. Medical-endorsed dispensaries must now employ a licensed pharmacist or medical cannabis consultant, offer priority service measures like dedicated lines and advance ordering, stock all products OCM identifies as high medical need, and fulfill patient product requests within 24 hours.
Does the new law change what dispensaries must carry or how they price products?
The law does not set prices, but it does require medical-endorsed retailers to stock all products OCM designates as high medical need. Macrobusinesses, which are the only license type required to serve the medical market, must maintain retail locations in high medical need areas if they operate more than five locations.
How does this law affect social equity cannabis license applicants?
Social equity applicants may now hold up to four cannabis licenses with capped ownership stakes, an increase from the previous limit. The petition process for moving into higher license tiers also gives priority to social equity applicants.
Where to Learn More
The full text of the 2026 Omnibus Cannabis Bill is available at the Minnesota Office of the Revisor of Statutes. Legal analysis from Foley Hoag LLP and Harris Sliwoski LLP provide additional detail on licensing implications. The MN House Session Daily covered the bill's passage with commentary from the bill sponsors.
For a directory of licensed Minnesota dispensaries and their current medical endorsement status, visit mncannabishub.com/dispensaries. For ongoing updates on Minnesota cannabis law, bookmark our legal coverage section.